[1]
Uzma Faridi, Fahad Al-Mutairi, Humaira Parveen and Sahar Khateeb 2022. An in-vitro and in Silico Anticancer Study of FDA Approved Antidiabetic Drugs Glimepiride and Empagliflozin: Life Sciences-Biochemistry for better diagnosis and therapy. International Journal of Life Science and Pharma Research. 10, 2 (Jun. 2022), 52–57. DOI:https://doi.org/10.22376/ijpbs/lpr.2020.10.2.L52-57.